NASDAQ:UTMD Utah Medical Products (UTMD) Stock Forecast, Price & News $95.00 +1.08 (+1.15%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$94.00▼$95.6950-Day Range$90.90▼$97.4052-Week Range$80.10▼$109.50Volume7,920 shsAverage Volume8,480 shsMarket Capitalization$344.85 millionP/E Ratio20.17Dividend Yield1.24%Price TargetN/A ProfileProfileChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Utah Medical Products MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.87% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainability-1.13Upright™ Environmental ScoreNews SentimentN/AInsider TradingSelling Shares$65,429 Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.40 out of 5 starsMedical Sector178th out of 983 stocksSurgical & Medical Instruments Industry18th out of 98 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Utah Medical Products. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.87% of the float of Utah Medical Products has been sold short.Short Interest Ratio / Days to CoverUtah Medical Products has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Utah Medical Products has recently increased by 3.15%, indicating that investor sentiment is decreasing. Previous Next 1.7 Dividend Strength Dividend YieldUtah Medical Products pays a meaningful dividend of 1.26%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthUtah Medical Products has only been increasing its dividend for 1 years.Dividend CoverageThe dividend payout ratio of Utah Medical Products is 25.05%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 3.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreUtah Medical Products has received a 50.89% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Blood pressure monitors" and "Surgical instruments" products. See details.Environmental SustainabilityThe Environmental Impact score for Utah Medical Products is -1.13. Previous Next 3.3 News and Social Media Coverage News SentimentUtah Medical Products has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Utah Medical Products this week, compared to 1 article on an average week.Search Interest1 people have searched for UTMD on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Utah Medical Products to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Utah Medical Products insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $65,429.00 in company stock.Percentage Held by InsidersOnly 6.50% of the stock of Utah Medical Products is held by insiders.Percentage Held by Institutions70.04% of the stock of Utah Medical Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Utah Medical Products is 20.17, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 136.41.Price to Earnings Ratio vs. SectorThe P/E ratio of Utah Medical Products is 20.17, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 138.67.Price to Book Value per Share RatioUtah Medical Products has a P/B Ratio of 2.92. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Utah Medical Products (NASDAQ:UTMD) StockUtah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women and babies. Its products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal critical care, perinatology, and urology. The company was founded on April 21, 1978 and is headquartered in Midvale, UT.Read More Receive UTMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter. Email Address UTMD Stock News HeadlinesMay 27, 2023 | finance.yahoo.comUtah Medical Products (NASDAQ:UTMD) shareholders have earned a 14% return over the last yearMay 21, 2023 | americanbankingnews.comPaul O. Richins Sells 700 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD) StockJune 3, 2023 | Vantage Point (Ad)Instantly Find Hidden Trade OpportunitiesThere’s a tool that scans and picks the best stocks…how you approach the trades is up to you. But when you’re forecasting 1 – 3 days in advance, it’s not really a guessing game. Stop guessing and start predicting to add consistency to your trades… no matter what happens in the market. May 19, 2023 | americanbankingnews.comUtah Medical Products (NASDAQ:UTMD) Now Covered by StockNews.comMay 12, 2023 | msn.comUtah Medical Products (UTMD) Declares $0.30 DividendApril 25, 2023 | finance.yahoo.comUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2023April 7, 2023 | americanbankingnews.comFinancial Contrast: Utah Medical Products (NASDAQ:UTMD) & InVivo Therapeutics (NASDAQ:NVIV)March 31, 2023 | americanbankingnews.comShort Interest in Utah Medical Products, Inc. (NASDAQ:UTMD) Increases By 22.6%June 3, 2023 | Vantage Point (Ad)Instantly Find Hidden Trade OpportunitiesThere’s a tool that scans and picks the best stocks…how you approach the trades is up to you. But when you’re forecasting 1 – 3 days in advance, it’s not really a guessing game. Stop guessing and start predicting to add consistency to your trades… no matter what happens in the market. March 26, 2023 | finance.yahoo.comUtah Medical Products, Inc.'s (NASDAQ:UTMD) Stock's On An Uptrend: Are Strong Financials Guiding The Market?March 25, 2023 | msn.comHow Utah Is Protecting Workers Without the Baggage of Unions | OpinionMarch 11, 2023 | finance.yahoo.comUtah Medical Products (NASDAQ:UTMD) Could Be A Buy For Its Upcoming DividendMarch 5, 2023 | finance.yahoo.comThe Returns On Capital At Utah Medical Products (NASDAQ:UTMD) Don't Inspire ConfidenceFebruary 10, 2023 | finance.yahoo.comUtah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.295February 7, 2023 | msn.comUtah Medical Products declares $0.295 dividendJanuary 31, 2023 | msn.comUtah Medical Products GAAP EPS of $1.25, revenue of $13.58MJanuary 31, 2023 | finanznachrichten.deUtah Medical Products, Inc.: UTMD Reports Audited Year 2022 and Fourth Quarter Financial PerformanceJanuary 31, 2023 | finance.yahoo.comUTMD Reports Audited Year 2022 and Fourth Quarter Financial PerformanceJanuary 9, 2023 | finance.yahoo.comHere's Why We Think Utah Medical Products (NASDAQ:UTMD) Might Deserve Your Attention TodayDecember 26, 2022 | finance.yahoo.comUtah Medical Products, Inc. (NASDAQ:UTMD) is favoured by institutional owners who hold 65% of the companyDecember 11, 2022 | finance.yahoo.comUtah Medical Products (NASDAQ:UTMD) stock performs better than its underlying earnings growth over last five yearsDecember 6, 2022 | seekingalpha.comIs Utah Medical Products Suitable As A Defensive Overlay In Equity Portfolios?November 27, 2022 | finance.yahoo.comCalculating The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)November 13, 2022 | finance.yahoo.comUtah Medical Products Third Quarter 2022 Earnings: EPS: US$1.18 (vs US$1.15 in 3Q 2021)November 1, 2022 | finance.yahoo.comUtah Medical Products, Inc. Increases Regular Quarterly DividendOctober 25, 2022 | finance.yahoo.comUTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022October 17, 2022 | cnbc.comUtah's cookie war heats up in court – and on social mediaSee More Headlines UTMD Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart UTMD Company Calendar Last Earnings4/25/2019Ex-Dividend for 4/4 Dividend3/16/2023Dividend Payable4/04/2023Today6/02/2023Ex-Dividend for 7/6 Dividend6/15/2023Dividend Payable7/06/2023Next Earnings (Estimated)7/25/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNASDAQ:UTMD CUSIP91748810 CIK706698 Webwww.utahmed.com Phone(801) 566-1200Fax801-566-7305Employees178Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$4.71 Trailing P/E Ratio20.17 Forward P/E RatioN/A P/E GrowthN/ANet Income$16.47 million Net Margins32.68% Pretax Margin40.49% Return on Equity15.32% Return on Assets14.11% Debt Debt-to-Equity RatioN/A Current Ratio15.66 Quick Ratio14.02 Sales & Book Value Annual Sales$52.28 million Price / Sales6.60 Cash Flow$6.60 per share Price / Cash Flow14.40 Book Value$32.53 per share Price / Book2.92Miscellaneous Outstanding Shares3,630,000Free Float3,392,000Market Cap$344.85 million OptionableNot Optionable Beta0.19 Key ExecutivesKevin Leighton CornwellChairman, President, CEO & SecretaryBrian Lee KoopmanChief Financial Officer & ControllerPaul Olson RichinsIndependent DirectorKey CompetitorsOraSure TechnologiesNASDAQ:OSURCerusNASDAQ:CERSAnika TherapeuticsNASDAQ:ANIKAtrionNASDAQ:ATRIAccurayNASDAQ:ARAYView All CompetitorsInsiders & InstitutionsRoyce & Associates LPBought 2,696 shares on 5/23/2023Ownership: 0.900%JPMorgan Chase & Co.Bought 2,255 shares on 5/18/2023Ownership: 2.354%Paul O RichinsSold 700 sharesTotal: $65,429.00 ($93.47/share)State Street CorpBought 1,421 shares on 5/16/2023Ownership: 1.969%Geode Capital Management LLCBought 1,085 shares on 5/16/2023Ownership: 1.968%View All Insider TransactionsView All Institutional Transactions UTMD Stock - Frequently Asked Questions How have UTMD shares performed in 2023? Utah Medical Products' stock was trading at $100.53 at the beginning of 2023. Since then, UTMD shares have decreased by 5.5% and is now trading at $95.00. View the best growth stocks for 2023 here. When is Utah Medical Products' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 25th 2023. View our UTMD earnings forecast. How were Utah Medical Products' earnings last quarter? Utah Medical Products, Inc. (NASDAQ:UTMD) issued its quarterly earnings results on Thursday, April, 25th. The medical instruments supplier reported $0.84 earnings per share for the quarter. The medical instruments supplier earned $10.73 million during the quarter. Utah Medical Products had a trailing twelve-month return on equity of 15.32% and a net margin of 32.68%. How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products? Utah Medical Products announced a quarterly dividend on Tuesday, May 9th. Stockholders of record on Friday, June 16th will be paid a dividend of $0.295 per share on Thursday, July 6th. This represents a $1.18 annualized dividend and a yield of 1.24%. The ex-dividend date is Thursday, June 15th. Read our dividend analysis for UTMD. What ETFs hold Utah Medical Products' stock? ETFs with the largest weight of Utah Medical Products (NASDAQ:UTMD) stock in their portfolio include Royce Quant Small-Cap Quality Value ETF (SQLV), Is Utah Medical Products a good dividend stock? Utah Medical Products (NASDAQ:UTMD) pays an annual dividend of $1.18 per share and currently has a dividend yield of 1.26%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 25.05%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for UTMD. What is Kevin L. Cornwell's approval rating as Utah Medical Products' CEO? 8 employees have rated Utah Medical Products Chief Executive Officer Kevin L. Cornwell on Glassdoor.com. Kevin L. Cornwell has an approval rating of 43% among the company's employees. This puts Kevin L. Cornwell in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Utah Medical Products own? Based on aggregate information from My MarketBeat watchlists, some companies that other Utah Medical Products investors own include Simon Property Group (SPG), Walt Disney (DIS), UnitedHealth Group (UNH), Intuitive Surgical (ISRG), Altria Group (MO), SEI Investments (SEIC), Trupanion (TRUP), Visa (V), Ventas (VTR) and What is Utah Medical Products' stock symbol? Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD." Who are Utah Medical Products' major shareholders? Utah Medical Products' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (5.70%), BlackRock Inc. (5.49%), Dimensional Fund Advisors LP (4.26%), Rice Hall James & Associates LLC (3.15%), JPMorgan Chase & Co. (2.35%) and Ranger Investment Management L.P. (2.00%). Insiders that own company stock include Barbara A Payne, Barbara A Payne, Ernst G Hoyer, Kevin L Cornwell and Paul O Richins. View institutional ownership trends. How do I buy shares of Utah Medical Products? Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Utah Medical Products' stock price today? One share of UTMD stock can currently be purchased for approximately $95.00. How much money does Utah Medical Products make? Utah Medical Products (NASDAQ:UTMD) has a market capitalization of $344.85 million and generates $52.28 million in revenue each year. The medical instruments supplier earns $16.47 million in net income (profit) each year or $4.71 on an earnings per share basis. How many employees does Utah Medical Products have? The company employs 178 workers across the globe. How can I contact Utah Medical Products? Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The official website for the company is www.utahmed.com. The medical instruments supplier can be reached via phone at (801) 566-1200 or via fax at 801-566-7305. This page (NASDAQ:UTMD) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Utah Medical Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.